Amundi Asset Management US’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $4.68M | Buy |
42,174
+4,941
| +13% | +$549K | ﹤0.01% | 1022 |
|
|
2020
Q4 | $4.42M | Buy |
37,233
+4,729
| +15% | +$562K | ﹤0.01% | 998 |
|
|
2020
Q3 | $2.84M | Buy |
32,504
+6,861
| +27% | +$598K | ﹤0.01% | 1016 |
|
|
2020
Q2 | $2.3M | Buy |
25,643
+2,084
| +9% | +$187K | ﹤0.01% | 1032 |
|
|
2020
Q1 | $2.35M | Sell |
23,559
-10,238
| -30% | -$1.02M | ﹤0.01% | 913 |
|
|
2019
Q4 | $3.88M | Buy |
33,797
+9,298
| +38% | +$1.07M | ﹤0.01% | 967 |
|
|
2019
Q3 | $3.09M | Buy |
+24,499
| New | +$3.09M | ﹤0.01% | 987 |
|
|
2019
Q2 | – | Sell |
-7,391
| Closed | -$647K | – | 1653 |
|
|
2019
Q1 | $647K | Hold |
7,391
| – | – | ﹤0.01% | 1265 |
|
|
2018
Q4 | $739 | Buy |
7,391
+5,466
| +284% | +$547 | ﹤0.01% | 1195 |
|
|
2018
Q3 | $221K | Buy |
+1,925
| New | +$221K | ﹤0.01% | 1407 |
|